- Home
- ACIU vs FXNC Comparison
ACIU vs FXNC Comparison
Compare ACIU & FXNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- FXNC
- Stock Information
- Founded
- ACIU 2003
- FXNC 1907
- Country
- ACIU Switzerland
- FXNC United States
- Employees
- ACIU N/A
- FXNC N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- FXNC Major Banks
- Sector
- ACIU Health Care
- FXNC Finance
- Exchange
- ACIU Nasdaq
- FXNC Nasdaq
- Market Cap
- ACIU 247.4M
- FXNC 201.9M
- IPO Year
- ACIU 2016
- FXNC N/A
- Fundamental
- Price
- ACIU $1.98
- FXNC $22.55
- Analyst Decision
- ACIU Strong Buy
- FXNC Strong Buy
- Analyst Count
- ACIU 2
- FXNC 1
- Target Price
- ACIU $12.00
- FXNC $21.00
- AVG Volume (30 Days)
- ACIU 197.4K
- FXNC 30.6K
- Earning Date
- ACIU 03-13-2025
- FXNC 04-29-2025
- Dividend Yield
- ACIU N/A
- FXNC 2.74%
- EPS Growth
- ACIU N/A
- FXNC N/A
- EPS
- ACIU N/A
- FXNC 1.00
- Revenue
- ACIU $30,136,397.00
- FXNC $58,015,000.00
- Revenue This Year
- ACIU $120.91
- FXNC $57.53
- Revenue Next Year
- ACIU $13.82
- FXNC $4.24
- P/E Ratio
- ACIU N/A
- FXNC $22.65
- Revenue Growth
- ACIU 84.51
- FXNC 18.29
- 52 Week Low
- ACIU $1.95
- FXNC $14.50
- 52 Week High
- ACIU $4.98
- FXNC $26.97
- Technical
- Relative Strength Index (RSI)
- ACIU 27.05
- FXNC 39.24
- Support Level
- ACIU $1.95
- FXNC $22.05
- Resistance Level
- ACIU $2.05
- FXNC $24.05
- Average True Range (ATR)
- ACIU 0.13
- FXNC 0.60
- MACD
- ACIU -0.02
- FXNC 0.11
- Stochastic Oscillator
- ACIU 6.38
- FXNC 39.02
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About FXNC First National Corporation
First National Corp is a bank holding company of First Bank, which is a commercial bank. Its core offering includes loans, deposits, wealth management, and other products and services. Loan products and services include personal loans, residential mortgages, home equity loans, and commercial loans. Deposit products and services include checking and savings. The Bank's wealth management division offers estate planning, investment management of assets, retirement accounts, and estate settlement.